Nurolzia NT Tablet contains a combination of Pregabalin 75mg and Nortriptyline 10mg, formulated to provide effective management of neuropathic pain and certain chronic pain conditions. Pregabalin, an anticonvulsant and analgesic agent, acts by modulating calcium channels in the central nervous system, thereby reducing the release of neurotransmitters involved in pain transmission. Nortriptyline, a tricyclic antidepressant, enhances pain relief through its action on the reuptake inhibition of norepinephrine and serotonin, contributing to improved mood and analgesic effects. This combination is particularly beneficial in patients with diabetic neuropathy, postherpetic neuralgia, or fibromyalgia, where monotherapy may be insufficient. Nurolzia NT is prescribed to alleviate symptoms such as burning, shooting pain, and hypersensitivity, improving patient quality of life. The tablet should be taken as directed by a healthcare professional, with dosage adjustments based on therapeutic response and tolerability. Common side effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disorders, or a history of seizures. Concomitant use with other central nervous system depressants should be monitored closely. Pregnant or breastfeeding women should consult their physician before use. Regular follow-up is recommended to assess efficacy and safety.